Related references
Note: Only part of the references are listed.The Prodromal Phase of Leucine-Rich Repeat Kinase 2-Associated Parkinson Disease: Clinical and Imaging Studies
Claustre Pont-Sunyer et al.
MOVEMENT DISORDERS (2017)
DNM3 and genetic modifiers of age of onset in LRRK2 Gly2019Ser parkinsonism: a genome-wide linkage and association study
Joanne Trinh et al.
LANCET NEUROLOGY (2016)
Equating scores of the University of Pennsylvania Smell Identification Test and Sniffin' Sticks test in patients with Parkinson's disease
Michael Lawton et al.
PARKINSONISM & RELATED DISORDERS (2016)
Nonmotor Symptoms in Healthy Ashkenazi Jewish Carriers of the G2019S Mutation in the LRRK2 Gene
Anat Mirelman et al.
MOVEMENT DISORDERS (2015)
Conversion Between Mini-Mental State Examination, Montreal Cognitive Assessment, and Dementia Rating Scale-2 Scores in Parkinson's Disease
Inger van Steenoven et al.
MOVEMENT DISORDERS (2014)
Olfactory identification in LRRK2 G2019S mutation carriers: a relevant marker?
Rachel Saunders-Pullman et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2014)
Olfaction and imaging biomarkers in premotor LRRK2 G2019S-associated Parkinson disease
Maria Sierra et al.
NEUROLOGY (2013)
The Age at Motor Symptoms Onset in LRRK2-Associated Parkinson's Disease is Affected by a Variation in the MAPT Locus: A Possible Interaction
Ziv Gan-Or et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2012)
Age at Onset in LRRK2-Associated PD is Modified by SNCA Variants
Teresa Botta-Orfila et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2012)
Motor signs in the prodromal phase of Parkinson's disease
Walter Maetzler et al.
MOVEMENT DISORDERS (2012)
Penetrance of LRRK2 G2385R and R1628P is modified by common PD-associated genetic variants
Chaodong Wang et al.
PARKINSONISM & RELATED DISORDERS (2012)
Brain-derived neurotrophic factor (BDNF) genetic polymorphism greatly increases risk of leucine-rich repeat kinase 2 (LRRK2) for Parkinson's disease
Jia Liu et al.
PARKINSONISM & RELATED DISORDERS (2012)
The Curious Case of Phenocopies in Families with Genetic Parkinson's Disease
Christine Klein et al.
MOVEMENT DISORDERS (2011)
Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers
C. Marras et al.
NEUROLOGY (2011)
The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study
Jeanne C. Latourelle et al.
BMC MEDICINE (2008)
Transcranial sonography findings in a large family with homozygous and heterozygous PINK1 mutations
J. M. Hagenah et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
Daniel G. Healy et al.
LANCET NEUROLOGY (2008)
Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale Presentation and Clinimetric Testing Results
Christopher G. Goetz et al.
MOVEMENT DISORDERS (2008)
Evaluation of LRRK2 G2019S penetrance -: Relevance for genetic counseling in Parkinson disease
S. Goldwurm et al.
NEUROLOGY (2007)
The Unified Parkinson's Disease Rating Scale (UPDRS): Status and recommendations
CG Goetz et al.
MOVEMENT DISORDERS (2003)